Search
for
Sort by
Research 181–210 of 1000+
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Drug Induced Alopecia
- Transethosomes: A Breakthrough System for Transdermal and Topical Drug Delivery
- Drug-Induced Hair Changes
- Role of Drug Repurposing in Sustainable Drug Discovery
- Transfollicular drug delivery: current perspectives
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Contemporary drug synthesis
- Niosomes as a propitious carrier for topical drug delivery
- Microneedles as Enhancer of Drug Absorption Through the Skin and Applications in Medicine and Cosmetology
- Drug-Induced Hair Disorders
- Drug Delivery with Topically Applied Nanoparticles: Science Fiction or Reality?
- Cutaneous Drug Delivery: An Update
- Getting under the skin: what is the potential of the transfollicular route in drug delivery?
- Derma rollers in therapy: the transition from cosmetics to transdermal drug delivery
- Recent Advances in Polymer Microneedles for Drug Transdermal Delivery: Design Strategies and Applications
- Special Focus Issue: Transdermal, Topical and Folicular Drug Delivery Systems
- Methodologies to Evaluate the Hair Follicle-Targeted Drug Delivery Provided by Nanoparticles
- [Drug induced alopecia].
- Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle
- Nanofiber Scaffolds as Drug Delivery Systems Promoting Wound Healing
- Chapter 14 Principles of drug metabolism
- Ethosome as a potential transdermal drug delivery system
- Related Topic: Drug Permeation Through Hair Follicles
- Percutaneous drug delivery to the hair follicle
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Microneedle-Based Technologies for Long-Acting Transdermal Drug Delivery in Wearable Devices